Cheng, Shu-HsingShu-HsingChengLien, Chia EnChia EnLienSZU-MIN HSIEHCheng, Chien-YuChien-YuChengWANG-DA LIULo, Ching-LungChing-LungLoKo, Wen-ChienWen-ChienKoChen, Yen-HsuYen-HsuChenHuang, Ching-TaiChing-TaiHuangChang, Hsiao-TingHsiao-TingChangHwang, Shinn-JangShinn-JangHwangWang, Ning-ChiNing-ChiWangLiu, Ming-CheMing-CheLiuLee, Yu-LinYu-LinLeeTai, I-ChenI-ChenTaiEstrada, Josue Antonio GarciaJosue Antonio GarciaEstradaLin, Tzou-YienTzou-YienLinLee, Wen-SenWen-SenLee2023-02-142023-02-142023-012076-393Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/628041This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH).enCD4/CD8 ratio; COVID-19 vaccine; CpG 1018; HIV; S-2P protein; immunogenicity[SDGs]SDG3journal article10.3390/vaccines11010018366798622-s2.0-85146821385WOS:000918966600001https://api.elsevier.com/content/abstract/scopus_id/85146821385